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Abstract
All species, including humans, are cohabited by a myriad of micro-
bial species, which massively influences body function in a diet-,
exercise- and age-dependent manner. The microbiome composi-
tion differs between individuals, partly due to the polymorphic
immune system, as well as the environment, making the microbe–
host interplay unique in each one of us. Ageing is a gradual loss of
function in part due to reduced repair mechanisms and accumula-
tion of tissue damage through mechanisms largely unknown.
Accumulating evidence suggests that our indigenous microbes, a
known major regulator of human physiology, are also connected
to regulate the ageing process through signalling pathways and
metabolites though the biological mechanisms are unknown. At
an ageing meeting in Singapore in 2018, investigators discussed
the current understanding of microbe regulation and its impact
on healthy ageing. This review summarizes the highlights from
the meeting and conveys some of the new ideas that emerged
around gut microbes and the biology of ageing. While highly spec-
ulative, an idea emerged in which gut microbes constantly
respond and evolve to environmental cues, as part of an ageing
process, thus serving as a second messenger to support and atten-
uate organ decline in a diet-, gender- and age-dependent manner.
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Gut microbes and the host—a unique mosaic of microbes
and organs that build and shape the human body
Throughout evolution, complex organisms have acquired prokary-
otic organelles such as mitochondria and chloroplasts to optimize
biological functions (Gilbert et al, 2012; Douglas, 2014). Human
beings coexist in a complex symbiotic relationship with more than a
1,000 different bacterial species in and on our bodies (Qin et al,
2010). These indigenous microbes occupy multiple niches in a
temporal and spatial fashion through mechanisms that are largely
unknown. The predominant location of microbes is in the alimen-
tary tract (Kundu et al, 2017), where they execute numerous
functions including securing nutritional supply through highly
sophisticated metabolic circuits.
Current models suggest that microbes massively influence host
physiology (Brown et al, 2013; Hooper et al, 2001, 2002; Nicholson
et al, 2012, Natarajan & Pluznick, 2014). The intensity and dynam-
ics of these interactions between the host and the microbes are
highly variable due to large differences in microbiome composition
and diversity. Therefore, each individual is a unique composite of
eukaryotic genes and microbes that collectively impact body func-
tion and well-being in a diet-, sex- and age-dependent manner
(Leser & Mølbak, 2009; Spor et al, 2011). That is, the mechanisms
by which microbiome composition, richness, and metabolites tune
organ maturation, formation of body homeostasis, and function in a
human being in early life are likely to also be good predictors for
microbiome-associated regulation of both healthy ageing and
diseases such as type II diabetes, cardiovascular perturbations,
neurodegenerative diseases and cancer.
Birth, postnatal life and the first acquisition of
maternal microbes
The newborn mammalian offspring acquires colonizing microbes
predominantly from the birth canal during vaginal delivery from the
mother, thereby providing a trajectory of early maternal colonizers
dominated by Lactobacillus, Bifidobacter and Prevotella spp (Domin-
guez-Bello et al, 2010). This biologically selected pathway of child
delivery is currently under threat due to the rapidly increasing
number of children delivered by Caesarean section. Recent data
suggest an early microbiome composition different to those under-
going vaginal delivery, thereby changing the evolutionary selected
symbiotic vertical transmission of maternal microbes (Dunn et al, 2017).
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In addition, highly controversial reports suggest that exposure to
microbes may occur before birth in the womb (Bearfield et al, 2002;
Markenson et al, 2003; Jime´nez et al, 2005; Rautava et al, 2012;
Hou et al, 2013; Stout et al, 2013; Aagaard et al, 2014; Ma¨ndar et al,
2015; Zheng et al, 2015; Verstraelen et al, 2016), thus challenging
the sterile womb dogma (Stout et al, 2013). While fascinating, it
remains to be excluded that the presence of these microbes may be
experimental contamination processes. Less controversial are the
reports showing that maternal microbes are also transmitted to
newborns via breast milk (Heikkila¨ & Saris, 2003; Martı´n et al,
2003; Beasley & Saris, 2004), which provide them with approxi-
mately 8 × 104 to 8 × 106 bacteria daily (Heikkila¨ & Saris, 2003).
That is, breastfeeding is a powerful way of enhancing the coloniza-
tion process and increasing the microbial diversity and thus the
maturation of the gut microbiome (higher levels of Bifidobacterium
species, characterized by Firmicutes bacteria) (Stewart et al, 2018).
As the growing child develops, the microbiome undergoes a contin-
uum of changes in diversity and species. A longitudinal study was
performed on stool samples from 903 children aged between 3 and
46 months as part of the Environmental Determinants of Diabetes in
the Young (TEDDY) study. 16S rRNA gene sequencing and metage-
nomic sequencing revealed that the gut microbiome progresses in
what the investigators characterize as a step-dependent manner; an
early developmental phase lasting up to 14 months of age, an
expanding transitional phase up to 30 months of age followed by
the entry into a stable phase up to 46 months (Stewart et al, 2018).
These changes in early life coincide with the gradual exposure to
different diets including solid food, which significantly impact and
further diversify microbiome composition and diversity by a rapid
expansion of anaerobes.
Glossary
Bio-active – having a biological effect.
Calorific value – energy contained in food, determined by measuring the
heat produced by the complete breakdown of it.
Circadian rhythmicity – is a roughly 24-h cycle in the physiological
processes of living beings. It is usually endogenously generated and can
be modulated by external cues such as sunlight and temperature.
Cognitive ability – general mental capability involving reasoning,
problem-solving, planning, abstract thinking, complex idea
comprehension and learning from experience.
Cognitive function – refers to multiple mental abilities such as learning,
thinking, reasoning, attention, remembering, problem solving and decision
making.
Degenerative pathways – pathways resulting in changes that affect
tissues and organs to deteriorate increasingly over time.
Disease susceptibility – an increased likelihood of developing a disease
based on the genetic make-up, often due to the inheritance of a genetic
variation from the parent.
Diurnal rhythmicity – patterns of activity or behaviour that follow the
day and night cycle, repeating every 24 h.
Dysbiosis – a term used for a microbial imbalance on or inside the body,
such as an impaired microbiota where microbiome become deranged,
with predominant species being underrepresented and normally
contained species increasing to fill the void.
Ecological niche – the role and position a species has in its
environment; how it meets its needs for food and shelter, how it survives,
and how it reproduces.
Glycaemic index – is the value assigned to foods based on how slowly or
how quickly they cause increases in blood glucose levels. It is a number from 0
to 100 assigned to a food, with pure glucose arbitrarily given the value of 100.
Holistic interventions – economical, non-invasive, non-pharmacologic
alternatives to traditional medical care that expand the repertoire of
therapies to manage and control diseases.
Induced pluripotent stem cell – adult cells that have been genetically
reprogrammed to an embryonic stem cell-like state by being forced to express
genes and factors important for maintaining the defining properties of
embryonic stem cells.
Mass spectrometry – an analytical technique that measures the mass-
to-charge ratio of ions in order to quantify known materials, identify
unknown compounds within a sample and to elucidate the structure and
chemical properties of different molecules.
Metabolite – intermediate end product of metabolism, usually a small
molecules.
Metabolome map – a map of the global collection of low molecular
weight metabolites produced by cells during metabolism providing a
functional readout of cellular activity and physiological status.
Metabolome – complex set of small molecule chemicals found within a
cell, organelle, tissue, biofluid or the entire organism.
Microbiome – the microorganisms in a particular environment of the
body or a part of the body.
Neural niche – a zone in which stem cells are retained after embryonic
development for the production of new cells for the nervous system.
Neurodegenerative diseases – conditions that primarily affect the
neurons in the brain and spinal cord causing them to die or be
damaged. Examples of diseases would be Parkinson’s, Alzheimer’s and
Huntington’s.
Neurotoxic effects – damage to the peripheral or central nervous
systems due to the exposure to natural or man-made toxic
substances, which can alter the activity of the nervous system to
disrupt or kill nerves.
Niche – a specialized and specific zone or area.
Non-senescent – organisms that do not exhibit any measurable
decline in survival characteristics such as strength or mobility with
age, do not have a gradually increasing death rate with age and
also do not exhibit any measurable reduction in reproductive ability
with age.
Operant paradigm – behaviour that is modifiable and controlled by its
consequences.
Personalized nutrition – an approach that uses information on
individual characteristics to develop targeted nutritional advice, products,
or services to assist individuals achieve lasting beneficial dietary
behaviour changes.
Phenotype – a composite of the individual’s observable characteristics as
a result of the interaction between its genotype with the environment.
Physiology – the way in the body or specific body parts and organs
function and interact with one another.
Plasticity – the ability of living organisms to change their “state” in
response to any stimuli and showing an adaptive response for optimal
survival.
Polymorphic – a discontinuous genetic variation resulting in the
occurrence of different types of individuals among the members of a
single species.
Post-prandial – during or relating to the period after meal: dinner or
lunch.
Precision medicine – also known otherwise as personalized medicine, is
an approach to patient care that empowers healthcare providers to select
and administer treatments most likely to be effective to patients based
on the genetic understanding of their disease.
Symbiotic – interaction between two different organisms living in close
physical and long-term biological association enabling a mutually
benefiting relationship.
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Diet is a major driver of microbiome diversification
The young human gradually acquires the adult microbiome, result-
ing in what is commonly known as the mature microbiome (Borre
et al, 2014). A trademark of the adult microbiome is its stability,
which possesses the ability to mitigate transient effects of stress, a
potential disruptor of microbial stability (Borre et al, 2014). Despite
its stability, the gut microbes possess the ability to respond to envi-
ronmental cues. Hence, this opens the door to therapeutic interven-
tions specifically targeting the microbial community at the
individual level. For example, differences in environmental factors
(Kundu et al, 2017; Stewart et al, 2018) have been shown to influ-
ence microbiome composition and diversity.
A central function for gut microbes is their ability to digest
incoming food material. Many of the homeostatic interactions
between the mammalian host and its gut microbiome are indeed
mutually beneficial. Gut microbes have the capacity to produce
essential vitamins and amino acids (LeBlanc et al, 2011, 2013, 2017;
Rossi et al, 2011) and convert host-generated primary bile acids into
bio-active, secondary bile acids (David et al, 2014). In addition,
microbes also metabolize dietary plant polysaccharides (fibre) (Fis-
chbach & Sonnenburg, 2011) and support lipid absorption in the
intestinal canal (Semova et al, 2012).
Another important area of future research is to identify key
microbes that act like orchestral leaders, thereby guiding other
microbes to support and maintain physiological functions. For
example, microbes regulating tryptophan metabolism represent only
10% of the gut microbiome, suggesting a stringent control within
the microbiome community at an individual level. Moreover,
prolonged expression of indoles has been documented to support
longevity in several animal models including flies, worms and mice
(Sonowal et al, 2017). Interestingly, in a recent paper it was demon-
strated that certain microbes, such as Clostridium difficile, possesses
the ability to elicit signals to tryptophan metabolizing microbes
through the accessory gene regulator 1 quorum-sensing system
(Atg1). Activation of Atg1 induces the machinery to secrete indoles
by nearby microbe secretion (Kleino & Silverman, 2019). This mech-
anism is therefore a powerful virulence mechanism for Clostridium
difficile to begin colonizing the alimentary tract, as indoles are
known for bacterial replication. This example illustrates a situation
where microbes and host exhibit opposite needs resulting in disease
manifestation for the host. Future research should aim to identify,
which microbes, among the commensal microbes possess this abil-
ity to regulate indole secretion. Are we losing those indole inducers
as we age? Are there sexual dimorphisms in their numbers?
The gut microbiome also responds swiftly to dietary changes via
microbial-derived metabolites (De Filippo et al, 2010; Albenberg &
Wu, 2014; Conlon & Bird, 2015) such as short-chain fatty acids
(SCFAs). SCFAs are known to regulate the mTOR pathway, one of
the key longevity pathways (Cornu et al, 2013; Johnson et al, 2013;
Passtoors et al, 2013; Henrique Mazucanti et al, 2015; Park et al,
2015). Interestingly, a gradual loss of SCFA by age has been
reported, indicating a potential link between SCFA and ageing regu-
lating pathways (Kundu et al, 2017). The glycaemic index is a
system relying on measurement of blood sugar levels in response to
different foods, while assuming that different individuals have iden-
tical glycaemic responses to food. This assumption was in fact chal-
lenged in the cited study, which suggests that different people have
differential responses to identical foods (Zeevi et al, 2015), which
confirms that there is no “one-size-fits-all” diet that is optimal for
everyone. Another interesting study recently reported that microbes
producing SCFA possess the ability to increase expression of the
hormone FGF21 (Pathak et al, 2018). The recent observation that
FGF21 treatment using a gene therapy approach can combat
diabetes (Jimenez et al, 2018) implies that food products can be
used to increase microbe-derived SCFA production, which may
become a new intervention scheme to treat obesity and insulin resis-
tance.
Venturing into personalized nutrition via individual personal
profiling may produce a reduction in the post-prandial glucose
response and attenuate symptoms of pre- or type II diabetes (Franz
et al, 2002; American Diabetes Association, 2008), since what we
eat and when we eat impact our microbiome. This is an exciting and
novel concept, given the extensive microbial differences between
individuals and also an explorative avenue to attenuate accelerated
ageing. Moreover, micronutrient intervention therapies will have
much reduced side effects as compared to small molecule therapies.
Marine biologists have reported that microbes display diurnal
rhythmicity. Further, like our own body clock, a large fraction of
microbes are assumed to change functionality at different times of
the day (Franz et al, 2002; American Diabetes Association, 2008).
Host physiology and feeding rhythmicity determine microbiome
clock function. Therefore, controlling feeding behaviour affects
microbiome circadian rhythmicity and vice versa and represents
another promising area of future intervention strategies (Franz et al,
2002; American Diabetes Association, 2008). These strategies may
provide ways to tackle pandemic chronic diseases such as obesity
and type II diabetes. It was estimated that in 2016 about 1.9 billion
adults were overweight/obese (WHO, 2017a) and the number of
people with diabetes reached 422 million in 2014 (WHO, 2017b).
Given the reported association with changes in microbiome compo-
sition in obesity and diabetes (Ley et al, 2005; Tilg & Kaser, 2011;
Devaraj et al, 2013) and that diet is the major regulator of micro-
biome composition (Hildebrandt et al, 2009; Moschen et al, 2012),
it is worth exploring whether intervention strategies that change
microbiome composition can attenuate disease burden.
Experiments conducted on ageing mice subjected to a 30%
caloric restriction and fed with low fat diet that was enriched with
Lactobacillus showed extended lifespan and reduced inflammation,
as circulating lipopolysaccharides in the serum was reduced (Zhang
et al, 2013), exemplifying the potential of diet manipulation in regu-
lating the health of the elderly.
Large bowel microbiome function can be improved by employing
various dietary strategies (Ziemer & Gibson, 1998; Laparra & Sanz,
2010). Compounds like acetate and butyrate that are SCFAs have
large benefits in the gut. Acetylated starches are bound starches,
which resist breakdown in the small intestine, facilitated by bacte-
rial enzymes. An increase in resistant starch results in increased
butyrate levels and consumption of foods like BARLEYmax, which
has a low glycaemic index and significantly promotes bowel health
(Aoe et al, 2018). Accumulating data suggest reduction in SCFA
producing microbes as one ages (Biagi et al, 2013). While the mech-
anisms underlying this age-dependent change are currently
unknown, the BARLEYmax diet intervention holds promise for
future design of synthetic diet interventions to increase the number
of microbes producing SCFA among the elderly.
ª 2019 The Authors EMBO Molecular Medicine 11: e9872 | 2019 3 of 12
Musarrat Maisha Reza et al EMBO Molecular Medicine
It is generally assumed that a diverse microbiome is strongly
associated with a healthier body (Cho & Blaser, 2012), while the
lack of diversity has been correlated with disease and mortality.
Additionally, the diversity of our diet appears to proportionally
affect our microbiome and enhances its adaptability to environmen-
tal perturbations (Bolnick et al, 2014; Heiman & Greenway, 2016).
Profiling of biofluids can help elucidate the function of the micro-
biome. Recently, an attractive diet for healthy ageing from the
OmniHeart trial was shown to reduce blood pressure and triglyc-
erides (Appel et al, 2005; Miller et al, 2006; Dome´nech et al, 2014).
This diet contains several essential metabolites: guanidinoacetate
and phenylacetylglutamine p-cresol sulphate. The OmniHeart trial
tested three different diets, all with the same calorific value. One
diet was enriched in carbohydrates, the other in protein, and the
third diet in unsaturated fat. The protein-rich and unsaturated fat-
rich diets showed reduced blood pressure and blood lipids with a
reduction in the risk of heart disease over a next 10-year period
(Appel et al, 2005; Miller et al, 2006; Dome´nech et al, 2014). While
this diet is targeted specifically for the maintenance of a healthy
heart, it also has significant beneficial effects on brain health and
hence overall body health. Using the MIND diet, a hybrid of the
Mediterranean and DASH diet suggests that it is possible to decrease
the incidence of dementia and Alzheimer’s disease (Tangney, 2014;
Morris et al, 2015a,b). While further studies are highly warranted, it
seems our grandparents’ wisdom can add value to modern day
science, when they would tell us the benefits of eating a wide vari-
ety of food and consuming an inclusive diet. In fact, food intake that
has limited diversity of animal and plant products (i.e. white flour
and white sugar) severely restricts gut microbiome diversity
(Heiman & Greenway, 2016). That is, exposing the body to either a
plant- or animal-based diet even temporally drastically changes the
structure of the gut microbiome (David et al, 2014).
Ageing and the microbiome
There is a rapid expansion of an ageing population worldwide. For
example, 14% of the Australian population is over 65 and it is
predicted to rise to 22% by 2061 (Australian Bureau of Statistics,
2013) and 28% of the population in Singapore will be aged 65 or
older by 2030 (Siau, 2017). Hence, more resources should be allo-
cated to address the role of gut microbes in regulating the biology of
ageing in addition to other mechanistic studies revolving on the
physiology and pathophysiology of ageing. Current data suggest that
considerable changes in microbiome composition and diversity
occur early in life when the expanding microbiome is to be formed
and build the growing offspring (Kundu et al, 2017). Similarly, later
in life, when body function declines, due to gradual loss of function
and accumulation of organ damage, reduced number of stem cells
and reduced ability to repair the ageing body, the microbiome
appears to reduce in diversity and richness (O’Toole & Claesson,
2010). Interestingly, the reduction of diversity and richness are asso-
ciated with the degree of social interactions with other humans.
Reduced interactions with other people result in reduced microbial
diversity, thus implying social interactions as another way to support
microbiome richness and diversity (O’Toole & Claesson, 2010).
Because reduced diversity has been associated with increased
susceptibility to disease acquisition, further experiments are highly
warranted especially in the light of the rapidly growing population of
elderly often associated with increased isolation and detachment
from society (Cho & Blaser, 2012).
It has been shown in one of the initial works on microbiome and
ageing using sequencing of the 16S rDNA from elderly Caucasians
over 65 years of age that a significant shift occurs in the microbial
phyla during ageing, from Firmicutes to Bacteroidetes (Claesson
et al, 2011). While currently unknown, we speculate that these
changes in microbiome composition of an elderly person are an
internal image of the gradual accumulation of reduced organ func-
tion and reduced ability to maintain barrier integrity (Kundu et al,
2017). Interestingly, a study demonstrated that a gradual loss of
microbiome diversity is associated with a loss of social communica-
tion where the most reduced microbiome diversity was observed in
individuals with reduced social interactions (Cho & Blaser, 2012;
Kundu et al, 2017). Like humans, microbial communities work in
concerted action to achieve common goals, like reducing energy
consumption to access nutrients, etc. Hence, a microbiome with
reduced diversity may therefore have multi-detrimental conse-
quences for the ageing human being.
Ageing is also associated with gradual cognitive and structural
changes in the brain. Research during the last 10 years has demon-
strated that gut microbes are linked to the formation of the blood–
brain barrier, myelination, neurogenesis, microglial maturation and
behaviour. Studies using germ-free mice have also demonstrated
that gut microbes influence behaviour, anxiety and fear linking fear
and anxiety to the microbiome (Bravo et al, 2011; Heijtz et al, 2011;
Cryan & Dinan, 2012; Kundu et al, 2017). This field of research is
currently subject to intensive investigations and some promising
small studies, essentially all in animal models, have identified poten-
tial key players with an ability to reduce stress responses, influence
anxiety and change behaviour, including social interactions (Sudo
et al, 2004; Bercik et al, 2011; Bravo et al, 2011; Gareau et al, 2011;
Heijtz et al, 2011; Ait-Belgnaoui et al, 2012, 2014; Hsiao et al, 2013;
Buffington et al, 2016). Recent microbiome profiling reports indicate
that changes in microbiome composition have been shown to corre-
late with neurodegenerative diseases such as Alzheimer’s (Chen
et al, 2016) and Parkinson’s (Jost, 1997; Pfeiffer & Quigley, 1999;
Hardoff et al, 2001; Kelly et al, 2014; Fasano et al, 2015) (Fig 1).
However, more research is needed, especially in humans, before
we can conclude whether human probiotic interventions will become
a new treatment module in our attempt to support healthy ageing and
attenuate accelerated ageing and onset of age-related disease.
Assessing case studies of Parkinson’s disease (Parkinson’s, UK,
2018) and cancer (Cancer Research UK) in the UK, these diseases
are strongly associated with age (Chu & Kordower, 2007), with a
significant rise in the incidence of Parkinson’s disease and cancer
from the 60–64 age bracket until 75–79 years of age. These focused
studies elucidate correlation between ageing and disease. In addi-
tion, the remaining surviving population of individuals over the age
of 80 may have entirely bypassed the age-related chronic diseases,
either due to genetic reasons, the environment they have lived in or
even a change in their bodies to support extreme ageing. The extre-
mely old population, including centenarians who live beyond
100 years of age, has an even more distinct and unique microbial
footprint as compared to the elderly (Biagi et al, 2010, 2016). The
centenarians are populated with Akkermansia, Christensenellaceae
and Bifidobacterium (Biagi et al, 2016). This variation is even
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greater than the difference in microbiome population observed
between young adults and the elderly with an age gap of approxi-
mately 40 years (Biagi et al, 2016). While no direct causality has
been shown, this raises the possibility of the existence of pro-ageing
microbiome that could facilitate a healthier population, which could
go on to live a much longer life, allowing extreme ageing.
Ageing is the gradual loss of organ function at a
systemic level
Ageing has been described as an age-dependent increase in failure
rates of the organs in the human body. In most cases, this is due to
a gradual loss of function in response to reduced ability to repair
and support tissues with oxygen and nutrients. Importantly, the
human body is a closed system and all organs are connected to one
another. Perturbation in one organ often impacts other organs via
inter-organ crosstalk. Failure of the system occurs when there is a
deviation of the homeostatic body function from the expected opti-
mal function (Deshpande et al, 1986; Gavrilov & Gavrilova, 2001;
Lai & Xie, 2006). It can thus be proposed that it is the body system’s
redundancy for the irreplaceable elements (the organs that work
together) that is responsible for ageing (Deshpande et al, 1986;
Gavrilov & Gavrilova, 2001; Lai & Xie, 2006). While ageing occurs
in all organs, promising examples of holistic interventions (calorie
restriction, drugs such as rapamycin, lifestyle alteration and supple-
ments) have shown that ageing can be slowed down. Furthermore,
the introduction of induced pluripotent stem (iPS) cell transplanta-
tion and whole-organ transplantation implies that we can expect
changes in the average lifetime of a human being.
Assuming that ageing occurs when the inter-organ communica-
tion fails to maintain homeostasis and not just due to the failure in
one step/process, we can envisage new ways to attenuate multiple
degenerative pathways in the body. This allows for optimism in
ageing and its management, where several mechanisms are targeted
to slow down ageing. Recently, the microbiome and diet have been
receiving much attention as a non-invasive method of targeting
ageing (Zhao & Shen, 2010).
Another feature of ageing is the gradual loss of barrier integrity,
reduced capillary bed to exchange waste products with nutrients and
oxygen, reduced cardiac output and respiration capacity. Collec-
tively, this is often manifested by increasing low-grade inflammation
that negatively impacts organ function through leakiness across
barriers of microbe-related inflammatory molecules, including
lipopolysaccharides. This barrier breach combined with impairment
in metabolic homeostasis occurs across the body including, for
example, skeletal muscle, liver, bone structures, adipocyte tissue,
oral cavity, skin and blood–brain barrier integrity, thus transmitting
partial immune activation of microglial cells and astrocytes in the
brain (Bischoff et al, 2014; Galland, 2014). While the observation of
low-grade inflammation is well documented, we are far from under-
standing the precise underlying mechanisms and this represents
another important area for future research of microbiome–host inter-
actions among elderly. Yet, some examples exist; metabolites like
D-lactic acid and ammonia, produced by bacterial enzymes, can
exert neurotoxic effects further affecting human behaviour (Galland,
2014) and changes to the microbiome have been reported to correlate
with chronic fatigue syndrome and fibromyalgia (Galland, 2014).
Hence, further studies are warranted to unravel the underlying
molecular mechanisms as well as to obtain a detailed metabolome
map to superimpose the changes in microbiome composition and
disease phenotype. Profiling the metabolome in conditions of
neurodegenerative diseases via different mass spectrometry tech-
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Figure 1. Disease prevalence in men and women with increasing age.
(Left) Graph showing the prevalence rates (per 100,000) of Parkinson’s in UK by age and gender in the year 2015. Graph (primary data) has been redrawn with the appropriate
authorization (Parkinson’s, UK 2018). The incidence and prevalence of Parkinson’s in the UK (London, UK). (Right) Graph showing the average number of new cases of cancer
per year for each age bracket as well as the incidence rate of cancer per 100,000 cases in the UK from 2013 to 2015. Graph (primary data) has been redrawn with the
appropriate authorization (Cancer Research UK 2018). Cancer incidence by age. Retrieved from https://www.cancerresearchuk.org/health-professional/cancer-statistics/
incidence/age#heading.
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metabolites, unlocks a better understanding for dietary interventions
that modify the microbiome to enhance health and cognitive func-
tion.
Lessons from ageing intervention therapies in the 21st
century of precision medicine
Nearly 30 years ago, longevity genes were identified in non-verte-
brate organisms following attempts to identify genes that are asso-
ciated with ageing. Although humans are at the top of the food
chain and possess the highest cognitive ability, studying other
organisms can provide us with deeper insights into pathways
controlling ageing. The hydra, for example, propagates asexually
as their stem cells do not fail to renew or regenerate and hence
are non-senescent (Schaible et al, 2011; Schaible & Sussman,
2013). In the search for longevity genes, the roles of APOE and
FOXO3A were examined. FOXO was then identified as a key regu-
lator of epithelial homeostasis and host–microbiome crosstalk.
FOXO3A is a signature protein related to ageing and its downreg-
ulation results in slow down of population growth rate. Hence, it
is known as a rate-of-ageing regulator (Schaible & Sussman,
2013).
Evidence from studies performed on yeast, fungi, nematodes,
insects, rodents and humans have now shown that mutations in
specific genes have the ability to reduce or extend lifespan as well
as accelerate ageing (Rattan, 2005). Moreover, several of these long-
evity genes have conserved function in ageing across species,
including mammals. Most prominent genes and biochemical path-
ways that have been identified with ageing are in the mTOR path-
way, the insulin-like growth factor/insulin pathway, sirtuins,
(Henrique Mazucanti et al, 2015) kinases and kinase receptors,
transcription factors, DNA helicases, telomerase, membrane glucosi-
dases, GTP-binding protein-coupled receptors, cholesterol metabo-
lism, heat shock protein genes and cell cycle arrest pathways to
name a few (Rattan, 2005).
Targeting these pathways increase the lifespan of mice and
delay the onset of disease (Henrique Mazucanti et al, 2015),
thereby holding promise for future tailor-made interventions for
humans. Notwithstanding the discovery of longevity genes,
ageing is an inevitable process for all living organisms and mani-
fests as a gradual loss of function across the body due to accu-
mulating damage across the different tissues (Lo´pez-Otı´n et al,
2013).
Aside from viewing ageing from a systemic approach, it could
also be coupled with targeting specific proteins and genes that have
been associated with ageing, thereby targeting ageing from both the
macro- and microperspective.
Biogerontology, which studies the biological basis of ageing,
seeks to prevent age-related diseases and enhance the quality of life
in old age by developing effective anti-ageing strategies. Survival
and longevity are strongly associated with maintenance and repair,
i.e. repairing DNA damage and removal of reactive oxygen species
(Rattan, 2005), often following inflammatory damage. The greater
the damage accumulated in cells, the shorter the lifespan of an indi-
vidual (Holliday, 2000).
However, anti-ageing research has often been associated with
pseudoscience and fraud, where overcoming ageing is promised
through miraculous remedies, which have no scientific evidence.
Anti-ageing therapies promise to prevent ageing, diseases and hence
death by prolonging lifespan, and most of them have been disap-
pointing and unsuccessful (Rattan, 2005).
Literature on ageing usually focuses on targeting specific age-
related diseases to cure or prevent a particular disease. However, it
does not target the process of ageing in itself. For example, cancer
therapy aims to remove cancer cells and achieve pre-disease state of
the affected organ. While the therapy reduces the rate of mortality
and aims to restore previous state of health, it does not address
other diseases associated with ageing such as Parkinson’s, Alzhei-
mer’s, dementia, frailty or cumulative organ failure. This is turn
highlights the lack of exploration on “how to attenuate processes
associated with accelerated ageing” as a principle in itself (Rattan,
2005). Other anti-ageing strategies aim to slow down ageing by
inhibiting or delaying physiological and functional deterioration.
Supplementation with hormones such as growth hormones, mela-
tonin and oestrogen, or supplements containing antioxidants have
shown clinical benefits in treating aged patients. However, regula-
tion of the ageing process itself has again, not been explored
(Olshansky et al, 2002).
Targeted studies to eliminate one type of ageing-related damage
may assist in slowing down that specific ageing phenotype but the
overall impact may not be significant since the other compounding
factors of ageing remain unaltered. Since ageing is a systemic
phenotype (Gavrilov & Gavrilova, 2001), holistic interventions
targeting lifestyle (i.e. diet and exercise) are necessary if we want to
slow the ageing process.
Results from a highly recognized Finnish Geriatric (FINGER)
intervention study revealed the possible beneficial effects of atten-
uating cognitive decline through multi-domain lifestyle interven-
tions (Kivipelto et al, 2013; Rosenberg et al, 2018). The
recommendation for Alzheimer’s disease prevention would be a
treatment cocktail including neuro-transmitter modulators, neuro-
protectors, dietary intervention/medical food, risk factor interven-
tion, next-generation targets, and amyloid and tau lowering
molecules (Kivipelto et al, 2013). The one-size-does-not-fit-all
concept was reiterated along with tailored interventions for specific
at-risk profiles, combining non-pharmacological and pharmacologi-
cal treatments and using new technologies. It seems likely that
background genetic variation will also influence the effectiveness
of such personalized therapeutic regimes, particularly if they work
via altering the interaction between the host microbiome and the
immune system.
Little is known about the mechanisms and signalling pathways
underlying gut–brain communication. The major hurdle is the
complexity in which microbes can communicate with the brain, and
moreover, the myriad of output signals from CNS that modulate and
change the gut microbiome also referred to as “the evolving inner
self”. (Kundu et al, 2017). There are a number of recent association
studies where a dysbiotic microbiome combined with changes in
diet appear to impact conditions like neurodegenerative diseases
and chronic inflammation in the bowel, including irritable bowel
syndrome. While encouraging, these data are largely obtained from
transgenic animal models. There is an imminent need to obtain data
from epidemiological and prospective studies including both healthy
old people as well as those with defined diseases (Collado et al,
2016).
6 of 12 EMBO Molecular Medicine 11: e9872 | 2019 ª 2019 The Authors
EMBO Molecular Medicine Musarrat Maisha Reza et al
Can ageing be altered?
While global initiatives and research focus on developing solu-
tions for famine, diarrhoea and malnourishment, we have
acquired an entire new set of chronic diseases that occur later in
life, which has become one of the greatest challenges for human
health. There is a rapid and explosive change in chronic disease
spectrum (Rivera et al, 2002; Who & Consultation, 2003), which
cannot be explained by genetics alone. Rather, environmental
interactions including introduction of antibiotics, reduced exercise
and reduced cost for unhealthy food are likely factors. No doubt,
these changes have also massively altered our microbiome. There
is therefore an intense global research effort to identify the
biomarkers of ageing, predict age-related diseases and intervene
at an early stage (Zglinicki & Martin-Ruiz, 2005; DelaRosa et al,
2006; Simm et al, 2008; Martin-Ruiz et al, 2011). While successful
interventions, be it drugs, change of diet or lifestyle, can postpone
or attenuate the onset of ageing-related diseases, most efforts are
still focusing on these conditions in isolation, thereby missing the
holistic approach to maintaining body function among the elderly.
The transformation of human working conditions brought about
by the industrial revolution drastically exposed the limitations of
an ageing body with evident functional deficiencies and loss of
productivity of the elderly in our communities (Lee, 2007). This
transition in part destroyed the ancient view of elderly as the
golden generation filled with wisdom and hence, an important
asset to society.
Moving forward to better understand biological ageing and to
reduce disease burden, a comprehensive perspective must be
applied. In addition, improved quality of life is intimately coupled to
breaking the pattern of disease occurring due to age, minimizing the
years of morbidity in each elderly individual and introducing effec-
tive interventions that can reduce disability and dependency
(Lunenfeld & Stratton, 2013). Successful ageing focuses on absence
of disease, enabling good physical and cognitive function and active
levels of social engagement (Bowling & Dieppe, 2005). Interestingly,
a recent report added to this phenomenon of successful ageing by
discussing the age-related association between disease susceptibility
and diversity of the microbiome (Cho & Blaser, 2012).
Importance of community for healthy ageing
Ageing is about understanding the accumulation of changes over
the years, including social, physical and psychological changes.
While function and dynamics of organs slow down in the ageing
body, concomitant with increased reaction time, age allows for the
expansion of human wisdom and knowledge of the world. Likewise,
the microbiome undergoes changes in composition and richness
presumed to be compensatory to the reduced physiological dynam-
ics in the heart, lung, and locomotion. However, wisdom combined
with a microbiome adaptation to age as such does not remove the
fact that the greatest risk to humans as it leads to an increasing risk
of disease acquisition.
Marmosets have been used to illustrate the benefits of ageing
and how they use social communication, which is acquired from
birth. Approximately 20 different social calls are acquired by
marmosets and they transfer their wisdom to subsequent
generations via social communication and function under the oper-
ant paradigm in a social family context (dominant, competitive,
sharing) (Clara et al, 2008). Social calls are different for different
animals and the phenotype is adapted based on what is beneficial.
These marmosets undergo a wasting syndrome when they are
devoid of social communications due to the significant mental
stress, which highlights the construction of a neural niche after birth
that expands based on the environment (Clara et al, 2008). The
ecological niche, cognitive niche and neural niche are constructed
via the gut–brain axis, highlighting the role of the gut–brain axis
leading to rapidly evolving brain function. The wisdom accumulated
and generated in the older monkeys is passed on via communication
(Clara et al, 2008) strikingly similar to humans.
The marmosets have been studied to understand parallels with
the situations in communities that we live in. Like the marmosets,
could the elderly in our communities be deteriorating because of
the loss of communication and hence becoming more susceptible
to diseases? Indeed, loss of social interactions and increasing
disconnect from the society is generally assumed to be factors that
accelerate ageing and increase susceptibility to disease (Sorkin
et al, 2002; Holwerda et al, 2012). Notably, this applies also to the
microbiome community with a concomitant reduction in diversity
and richness among human beings becoming isolated (Claesson
et al, 2012).
Further, lack of interpersonal functions is a distinct feature in
schizophrenia. Many schizophrenic patients are devoid of social
relationships and this social detachment is a significant obstacle to
their recovery (Walker et al, 1993). Social interactions and
communication have an impact on human physiology and also the
microbiome.
Studies have shown that the elderly that live in a community-
centric environment had a unique microbial signature and a larger
tendency to consume a fibre-enriched diet, enhancing the microbial
diversity and reducing inflammation by downregulating inflamma-
tory factors including TNF-a, C-reactive protein and neopterin
(Claesson et al, 2012). Moreover, this elderly population also
displayed an increase in bacterial genes that are involved in metab-
olizing SCFAs such as acetate and butyrate (Claesson et al, 2012).
Community dwelling elderly showed a higher population of Firmi-
cutes in their microbiome as compared to a higher population of
Bacteroidetes in elderly that lived in isolation (Claesson et al,
2012).
These studies elegantly illustrate the perception that ageing does
not only need to be managed using physiological interventions.
Current society is unfortunately rapidly moving away from social
interactions to save money and time. Hence, expanding community
development may be a useful tool since it plays a paramount role in
healthy ageing.
Over the past decades, families no longer choose to live in large,
extended families, but rather opt for the nuclear family system
resulting in the “family decline” hypothesis (Bengtson, 2001). When
coupled with the rise of social media, this widens the communica-
tion barrier between the elderly and the rest of the family (as well
as the microbial exposure). The lack or inability of elders to commu-
nicate among the family, i.e. use their social calls or pass down their
wisdom, could also be a factor to look into when designing holistic
solutions to enable active ageing or delay wasting in the elderly
populations.
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Research is about re-discovery: learning from the ancient
greek philosophers and their perceptions of ageing
The ancient philosophers addressed ageing from a societal and
holistic perspective. While extensively discussing youth and old
age, they reached a consensus that ageing is a matter of perception
with no clear boundaries. Plato, for instance, addressed the
concept of ageing from two stances, continuity and disengagement,
where he defined continuity as the ability of the elderly to persist
with the previous activities during their youth and referred to
disengagement when people drifted away from previous goals,
strategies and aims in life [105]. Applying Plato’s wisdom to 21st
century precision medicine and the concepts of physiological
ageing, healthy ageing can only be achieved if we maintain consis-
tency of robust living as we did in our youth. Negligence of our
health and wellness over the years results in the gradual slowing
down and hence, disengagement, spiralling towards conditions
predicted by Aristotle; illnesses and pain as companions of old age
(Gendlin & Gendlin, 2012).
Galen of Pergamon further developed these concepts around
humans in which he openly belittles the idea of combating or
preventing ageing. He highlighted that just as how a good gover-
nor would supply the city with food for winter, it is man’s duty
to accumulate his biggest wealth, his health so that he can enjoy
the fruits of it during his old age (Diamandopoulos, 2017).
Galen’s thoughtful views are applicable to our modern mindset,
to understand ageing from a biological and evolutionary perspec-
tive with the intention of attenuating or postponing the natural
process of ageing.
In the post-Pasteur microbial century of “good microbe” centred
perception, it follows that if we continue to support our microbes
with the temporal and spatial cues (diet, exercise, community expo-
sure and decreased stress) they require to maintain diversity and
thus homeostasis, it will undoubtedly have positive repercussions
on body function. This echoes the sentiments of Plutarch, who
advocated that we have the power to build up physical and mental
qualifications, which we are then able to exploit in our old age
(Trench, 1874). If we live an active and healthy life during our
youth, our old age will be more productive and manageable, similar
to the viewpoint of Galen.
What lies ahead?
The average lifespan in Classical Greece was reported to be
25 years but increased to 42 years after they crossed adulthood
due to high infant mortality (Angel, 1947), and it eventually
reached 72 years during the Roman period (Montagu, 1994).
Current statistics show that human beings are living longer in the
industrial world (Cervellati & Sunde, 2005) thus reflecting the fact
we as a species have accumulated experience and know-how for
a longer lifespan. Clearly, we are at the beginning of unravelling
mechanisms underlying ageing and it will take a long time to
transition from a reductionist mindset to understanding ageing
with a holistic perception. Yet, the recent re-discovery of the
indigenous microbes as a central player in human health and
disease provides optimism. If we assess the human body function
from a systems biology understanding of the ageing process,
Pending issues
(i) The mechanisms underlying microbiome changes by age and the
reasons are currently unknown. Current theories suggest impair-
ment in barrier integrity, thus allowing microbes to breach barri-
ers and indirectly elicit low-grade inflammation. Another theory
implies that gradual loss of organ function forces gut microbes
to respond to the reduced physiological efficacy and as a conse-
quence, increase in the generation of energy from the alimentary
tract to the host through changes in microbiome composition.
Both models are not mutually exclusive. More research is highly
warranted.
(ii) Increasing the knowledge by which microbes and microbial
metabolites influence signalling pathways and organ function
within an ageing organism across gender. Of outmost impor-
tance is to identify microbial metabolites that directly or
indirectly support healthy ageing or attenuate accelerated
ageing. This includes also molecules that stabilize barrier
integrity.
(iii) Undertake research to identify major “orchestral” microbe
leaders that directly or indirectly influence microbiome diver-
sity and richness relevant to its functions. An example is
Akkermansia.
(iv) We have yet to explore the first tailor-made microbiome inter-
vention study in line with the biology of a given individual. The
lessons from non-responder/responder experiments using probi-
otic intervention approach from the Elinav laboratory (Zmora
et al, 2018) tell us that us that more research is needed to estab-
lish proof of concept as well as who to target. Going forward this
has huge implications for a broader and deeper understanding
of healthy ageing.
(v) There is an unmet need to develop a better understanding of
how gut microbes and their metabolites contribute to organ-to-
organ communication either in early life or when organ function
declines by age. This includes also the topological distribution of
microbes in different compartments. For example, which are the
temporal–spatial cues that guide homing to a specific part of the
body?
(vi) Virtually nothing is known when microbes and the host end up
having opposing needs. When does this occur, what are the
signalling cues and underlying molecular mechanisms that trig-
ger these situations? Is there room for man-made interventions
that can attenuate the conflict of interest between microbes and
the host without massive violation of microbe–microbe interac-
tions, like we do with pathogens and antibiotics? Future experi-
ments involving antimicrobial peptides or phage therapy are
therefore of interest.
(vii) Utilizing existing knowledge by providing SCFA to increase
barrier integrity; does it come with unwanted side effects yet
to be discovered especially since SCFA also has the ability to
remodel chromatin structure? Systems biology analysis in
human cohort studies is therefore highly warranted and this
is an area where the food industry should together with
academia, clarify the effects of microbial intervention and
maintaining barrier function and overall metabolic homeosta-
sis.
(viii) The rapidly growing number of old people worldwide is inti-
mately associated with increased number of human beings with
chronic lifestyle diseases because of increased lifespan. There is
unmet need to undertake longitudinal studies among old people
that is not subject to disease. Within these groups of people,
there are those at risk to develop disease. A systems biology
approach including non-invasive fMRI analysis combined with
multiple omic analysis, metagenomics and metabonomics of
stool and fluid samples will open for discovery of novel biomark-
ers that can be used for future intervention studies prior to
disease at an individual level.
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which ancient philosophers have empowered us with, then ageing
will be as positive or negative as we believe. Using the gut micro-
biome as a target for future interventions with diet, microbial
metabolites and possibly certain probiotics suggests that we may
have a better control over how we choose to live our golden
years, either in bliss or in pain. As Goethe wrote in his letter to
Humboldt in 1732, 5 days before his death, “The ancients used to
say: Animals are instructed by their organs. I will add: Men are
too, but they have the advantage of being able to instruct their
organs in their turn”. Perhaps our indigenous gut microbes are
part of the second messenger instruction to our organs.
Acknowledgements
This review is a follow-up on the dynamic presentations and discussions
generated in workshop entitled, “The Microbiome in Host Physiology” at the
Lee Kong Chian School of Medicine, Nanyang Technological University, Singa-
pore, which took place in 22-24 March 2018. This workshop was jointly orga-
nized by Canadian Institute of Advanced Research (CIFAR), LKCMedicine and
Ageing Research Institute for Society and Education (ARISE), Nanyang Techno-
logical University. Our heartfelt gratitude to all the sponsors who supported
the “Microbiome in Host Physiology and Ageing” Workshop; Lee Kong Chian
School of Medicine, Nanyang Technological University (NTU); Ageing Research
Institute for Society and Education (ARISE), NTU; Singapore Centre for Environ-
mental Life Sciences Engineering (SCELSE), NTU; NUHS Centre for Healthy
Ageing, CSIRO, Australia; Bruker, U.S.A. Deepest appreciation to Professor
Richard Reynolds and Katherine Ann Martin for their feedback and editing of
this review and to Dr. Odayne Haughton for the inspiration and unwavering
trust in our work.
Conflict of interest
The authors declare that they have no conflict of interest.
References
Aagaard K, Ma J, Antony KM, Ganu R, Petrosino J, Versalovic J (2014) The
placenta harbors a unique microbiome. Sci Transl Med 6: 237ra65
Ait-Belgnaoui A, Durand H, Cartier C, Chaumaz G, Eutamene H, Ferrier L,
Houdeau E, Fioramonti J, Bueno L, Theodorou V (2012) Prevention of gut
leakiness by a probiotic treatment leads to attenuated HPA response to
an acute psychological stress in rats. Psychoneuroendocrinology 37:
1885 – 1895
Ait-Belgnaoui A, Colom A, Braniste V, Ramalho L, Marrot A, Cartier C,
Houdeau E, Theodorou V, Tompkins T (2014) Probiotic gut effect prevents
the chronic psychological stress-induced brain activity abnormality in
mice. Neurogastroenterol Motil 26: 510 – 520
Albenberg LG, Wu GD (2014) Diet and the intestinal microbiome:
associations, functions, and implications for health and disease.
Gastroenterology 146: 1564 – 1572
American Diabetes Association (2008) Nutrition recommendations and
interventions for diabetes: a position statement of the American Diabetes
Association. Diabetes Care 31(Suppl 1): S61 – S78
Angel JL (1947) The length of life in ancient Greece. J Gerontol 2: 18 – 24
Aoe S, Nakamura F, Fujiwara S (2018) Effect of wheat bran on fecal butyrate-
producing bacteria and wheat bran combined with barley on bacteroides
abundance in Japanese healthy adults. Nutrients 10: 1980
Appel LJ, Sacks FM, Carey VJ, Obarzanek E, Swain JF, Miller ER, Conlin PR,
Erlinger TP, Rosner BA, Laranjo NM et al (2005) Effects of protein,
monounsaturated fat, and carbohydrate intake on blood pressure and serum
lipids: results of the OmniHeart randomized trial. JAMA 294: 2455 – 2464
Australian Bureau of Statistics (2013). 3222.0 - Population Projections,
Australia, 2012 (base) to 2101. Retrieved from https://www.abs.gov.au/
ausstats/abs@.nsf/Lookup/3222.0main+features32012%20(base)%20to%
202101
Bearfield C, Davenport ES, Sivapathasundaram V, Allaker RP (2002) Possible
association between amniotic fluid micro-organism infection and
microflora in the mouth. BJOG 109: 527 – 533
Beasley SS, Saris PE (2004) Nisin-producing Lactococcus lactis strains isolated
from human milk. Appl Environ Microbiol 70: 5051 – 5053
Bengtson VL (2001) Beyond the nuclear family: the increasing importance
of multigenerational bonds: the burgess award lecture. J Marr Fam 63:
1 – 16
Bercik P, Denou E, Collins J, Jackson W, Lu J, Jury J, Deng Y, Blennerhassett P,
Macri J, McCoy KD et al (2011) The intestinal microbiota affect central
levels of brain-derived neurotropic factor and behavior in mice.
Gastroenterology 141: 599 – 609
Biagi E, Nylund L, Candela M, Ostan R, Bucci L, Pini E, Nikkïla J, Monti D,
Satokari R, Franceschi C et al (2010) Through ageing, and beyond: gut
microbiota and inflammatory status in seniors and centenarians. PLoS One
5: e10667
Biagi E, Candela M, Turroni S, Garagnani P, Franceschi C, Brigidi P (2013)
Ageing and gut microbes: perspectives for health maintenance and
longevity. Pharmacol Res 69: 11 – 20
Biagi E, Franceschi C, Rampelli S, Severgnini M, Ostan R, Turroni S,
Consolandi C, Quercia S, Scurti M, Monti D et al (2016) Gut microbiota
and extreme longevity. Curr Biol 26: 1480 – 1485
Bischoff SC, Barbara G, Buurman W, Ockhuizen T, Schulzke JD, Serino M, Tilg
H, Watson A, Wells JM (2014) Intestinal permeability–a new target for
disease prevention and therapy. BMC Gastroenterol 14: 189
Bolnick DI, Snowberg LK, Hirsch PE, Lauber CL, Knight R, Caporaso JG,
Svanbäck R (2014) Individuals’ diet diversity influences gut microbial
diversity in two freshwater fish (threespine stickleback and Eurasian
perch). Ecol Lett 17: 979 – 987
Borre YE, O’Keeffe GW, Clarke G, Stanton C, Dinan TG, Cryan JF (2014)
Microbiota and neurodevelopmental windows: implications for brain
disorders. Trends Mol Med 20: 509 – 518
Bowling A, Dieppe P (2005) What is successful ageing and who should define
it? BMJ 331: 1548 – 1551
Bravo JA, Forsythe P, Chew MV, Escaravage E, Savignac HM, Dinan TG,
Bienenstock J, Cryan JF (2011) Ingestion of Lactobacillus strain regulates
emotional behavior and central GABA receptor expression in a mouse via
the vagus nerve. Proc Natl Acad Sci USA 108: 16050 – 16055
Box 1: Invited speakers who were referred to in this review
(i) Dr. Paul Blatchford, Commonwealth Scientific & Industrial
Research Organization (CSIRO) Health and Biosecurity, Adelaide,
Australia
(ii) Professor Atsushi Iriki, Riken Brain Science Institute, Japan
(iii) Professor Dusko Ehrlich, King’s College, London, UK
(iv) Professor Elaine Holmes, Imperial College, London, UK
(v) Professor Eran Elinav, Weizmann Institute of Science, Israel
(vi) Professor Miia Kivipelto, Karolinska Institute
(vii) Professor Thomas Bosch, Zoologisches Institut, University of Kiel,
Germany
ª 2019 The Authors EMBO Molecular Medicine 11: e9872 | 2019 9 of 12
Musarrat Maisha Reza et al EMBO Molecular Medicine
Brown EM, Sadarangani M, Finlay BB (2013) The role of the immune system
in governing host-microbe interactions in the intestine. Nat Immunol 14:
660
Buffington SA, Di Prisco GV, Auchtung TA, Ajami NJ, Petrosino JF, Costa-
Mattioli M (2016) Microbial reconstitution reverses maternal diet-induced
social and synaptic deficits in offspring. Cell 165: 1762 – 1775
Cancer Research UK (2018). Cancer incidence by age. Retrieved from https://
www.cancerresearchuk.org/health-professional/cancer-statistics/incidence/
age#heading
Cervellati M, Sunde U (2005) Human capital formation, life expectancy, and
the process of development. Am Econ Rev 95: 1653 – 1672
Chen CH, Lin CL, Kao CH (2016) Irritable bowel syndrome is associated with
an increased risk of dementia: a nationwide population-based study. PLoS
ONE 11: e0144589
Cho I, Blaser MJ (2012) The human microbiome: at the interface of health
and disease. Nat Rev Genet 13: 260
Chu Y, Kordower JH (2007) Age-associated increases of a-synuclein in monkeys
and humans are associated with nigrostriatal dopamine depletion: is this
the target for Parkinson’s disease? Neurobiol Dis 25: 134 – 149
Claesson MJ, Cusack S, O’Sullivan O, Greene-Diniz R, de Weerd H, Flannery E,
Marchesi JR, Falush D, Dinan T, Fitzgerald G et al (2011) Composition,
variability, and temporal stability of the intestinal microbiota of the
elderly. Proc Natl Acad Sci USA 108(Suppl 1): 4586 – 4591
Claesson MJ, Jeffery IB, Conde S, Power SE, O’connor EM, Cusack S, Harris
HM, Coakley M, Lakshminarayanan B, O’sullivan O et al (2012) Gut
microbiota composition correlates with diet and health in the elderly.
Nature 488: 178
Clara E, Tommasi L, Rogers LJ (2008) Social mobbing calls in common
marmosets (Callithrix jacchus): effects of experience and associated cortisol
levels. Anim Cogn 11: 349 – 358
Collado MC, Rautava S, Aakko J, Isolauri E, Salminen S (2016) Human gut
colonisation may be initiated in utero by distinct microbial communities
in the placenta and amniotic fluid. Sci Rep 6: 23129
Conlon M, Bird A (2015) The impact of diet and lifestyle on gut microbiota
and human health. Nutrients 7: 17 – 44
Cornu M, Albert V, Hall MN (2013) mTOR in aging, metabolism, and cancer.
Curr Opin Genet Dev 23: 53 – 62
Cryan JF, Dinan TG (2012) Mind-altering microorganisms: the impact of the
gut microbiota on brain and behaviour. Nat Rev Neurosci 13: 701
David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE,
Ling AV, Devlin AS, Varma Y, Fischbach MA et al (2014) Diet
rapidly and reproducibly alters the human gut microbiome. Nature 505:
559
De Filippo C, Cavalieri D, Di Paola M, Ramazzotti M, Poullet JB, Massart S,
Collini S, Pieraccini G, Lionetti P (2010) Impact of diet in shaping gut
microbiota revealed by a comparative study in children from Europe and
rural Africa. Proc Natl Acad Sci USA 107: 14691 – 14696
DelaRosa O, Pawelec G, Peralbo E, Wikby A, Mariani E, Mocchegiani E,
Tarazona R, Solana R (2006) Immunological biomarkers of ageing in man:
changes in both innate and adaptive immunity are associated with health
and longevity. Biogerontology 7: 471 – 481
Deshpande JV, Kochar SC, Singh H (1986) Aspects of positive ageing. J Appl
Probabil 23: 748 – 758
Devaraj S, Hemarajata P, Versalovic J (2013) The human gut microbiome and
body metabolism: implications for obesity and diabetes. Clin Chem 59:
617 – 628
Diamandopoulos A (2017) The ideas of Plato, Aristotle, Plutarch and Galen on
the elderly. J Gerontol Geriatr 65: 325 – 328
Doménech M, Roman P, Lapetra J, García de la Corte FJ, Sala-Vila A, de la
Torre R, Corella D, Salas-Salvadó J, Ruiz-Gutiérrez V, Lamuela-Raventós
RM et al (2014) Mediterranean diet reduces 24-hour ambulatory blood
pressure, blood glucose, and lipids: one-year randomized, clinical trial.
Hypertension 64: 69 – 76
Dominguez-Bello MG, Costello EK, Contreras M, Magris M, Hidalgo G, Fierer
N, Knight R (2010) Delivery mode shapes the acquisition and structure of
the initial microbiota across multiple body habitats in newborns. Proc
Natl Acad Sci USA 107: 11971 – 11975
Douglas AE (2014) Symbiosis as a general principle in eukaryotic evolution.
Cold Spring Harb Perspect Biol 6: a016113
Dunn AB, Jordan S, Baker BJ, Carlson NS (2017) The maternal infant
microbiome: considerations for labor and birth. MCN Am J Matern Child
Nurs 42: 318 – 325
Fasano A, Visanji NP, Liu LW, Lang AE, Pfeiffer RF (2015) Gastrointestinal
dysfunction in Parkinson’s disease. Lancet Neurol 14: 625 – 639
Fischbach MA, Sonnenburg JL (2011) Eating for two: how metabolism
establishes interspecies interactions in the gut. Cell Host Microbe 10:
336 – 347
Franz MJ, Bantle JP, Beebe CA, Brunzell JD, Chiasson JL, Garg A, Holzmeister
LA, Hoogwerf B, Mayer-Davis E, Mooradian AD et al (2002) Evidence-based
nutrition principles and recommendations for the treatment and
prevention of diabetes and related complications. Diabetes Care 25:
148 – 198
Galland L (2014) The gut microbiome and the brain. J Med Food 17:
1261 – 1272
Gareau MG, Wine E, Rodrigues DM, Cho JH, Whary MT, Philpott DJ,
MacQueen G, Sherman PM (2011) Bacterial infection causes stress-
induced memory dysfunction in mice. Gut 60: 307 – 317
Gavrilov LA, Gavrilova NS (2001) The reliability theory of aging and longevity.
J Theor Biol 213: 527 – 545
Gendlin ET, Gendlin ET (2012) Line by line commentary on Aristotle’s De
Anima. Spring Valley, NY: Focusing Institute
Gilbert SF, Sapp J, Tauber AI (2012) A symbiotic view of life: we have never
been individuals. Q Rev Biol 87: 325 – 341
Hardoff R, Sula M, Tamir A, Soil A, Front A, Badarna S, Honigman S, Giladi N
(2001) Gastric emptying time and gastric motility in patients with
Parkinson’s disease. Mov Disord 16: 1041 – 1047
Heijtz RD, Wang S, Anuar F, Qian Y, Björkholm B, Samuelsson A, Hibberd
ML, Forssberg H, Pettersson S (2011) Normal gut microbiota modulates
brain development and behavior. Proc Natl Acad Sci USA 108:
3047 – 3052
Heikkilä MP, Saris PEJ (2003) Inhibition of Staphylococcus aureus by the
commensal bacteria of human milk. J Appl Microbiol 95: 471 – 478
Heiman ML, Greenway FL (2016) A healthy gastrointestinal microbiome is
dependent on dietary diversity. Mol Metab 5: 317 – 320
Henrique Mazucanti C, Victor Cabral-Costa J, Rodrigues Vasconcelos A, Zukas
Andreotti D, Scavone C, Mitiko Kawamoto E (2015) Longevity pathways
(mTOR, SIRT, Insulin/IGF-1) as key modulatory targets on aging and
neurodegeneration. Curr Top Med Chem 15: 2116 – 2138
Hildebrandt MA, Hoffmann C, Sherrill-Mix SA, Keilbaugh SA, Hamady M, Chen
YY, Knight R, Ahima RS, Bushman F, Wu GD (2009) High-fat diet
determines the composition of the murine gut microbiome independently
of obesity. Gastroenterology 137: 1716 – 1724
Holliday R (2000) Ageing research in the next century. Biogerontology 1:
97 – 101
Holwerda TJ, Beekman AT, Deeg DJ, Stek ML, van Tilburg TG, Visser PJ,
Schmand B, Jonker C, Schoevers RA (2012) Increased risk of mortality
10 of 12 EMBO Molecular Medicine 11: e9872 | 2019 ª 2019 The Authors
EMBO Molecular Medicine Musarrat Maisha Reza et al
associated with social isolation in older men: only when feeling lonely?
Results from the Amsterdam Study of the Elderly (AMSTEL). Psychol Med
42: 843 – 853
Hooper LV, Wong MH, Thelin A, Hansson L, Falk PG, Gordon JI (2001)
Molecular analysis of commensal host-microbial relationships in the
intestine. Science 291: 881 – 884
Hooper LV, Midtvedt T, Gordon JI (2002) How host-microbial interactions
shape the nutrient environment of the mammalian intestine. Annu Rev
Nutr 22: 283 – 307
Hou D, Zhou X, Zhong X, Settles ML, Herring J, Wang L, Abdo Z, Forney LJ, Xu
C (2013) Microbiota of the seminal fluid from healthy and infertile men.
Fertil Steril 100: 1261 – 1269
Hsiao EY, McBride SW, Hsien S, Sharon G, Hyde ER, McCue T, Codelli JA,
Chow J, Reisman SE, Petrosino JF et al (2013) Microbiota modulate
behavioral and physiological abnormalities associated with
neurodevelopmental disorders. Cell 155: 1451 – 1463
Jiménez E, Fernández L, Marín ML, Martín R, Odriozola JM, Nueno-Palop C,
Narbad A, Olivares M, Xaus J, Rodríguez JM (2005) Isolation of commensal
bacteria from umbilical cord blood of healthy neonates born by cesarean
section. Curr Microbiol 51: 270 – 274
Jimenez V, Jambrina C, Casana E, Sacristan V, Muñoz S, Darriba S, Rodó J,
Mallol C, Garcia M, León X et al (2018) FGF21 gene therapy as treatment
for obesity and insulin resistance. EMBO Mol Med 10: e8791
Johnson SC, Rabinovitch PS, Kaeberlein M (2013) mTOR is a key modulator of
ageing and age-related disease. Nature 493: 338
Jost WH (1997) Gastrointestinal motility problems in patients with
Parkinson’s disease. Drugs Aging 10: 249 – 258
Kelly LP, Carvey PM, Keshavarzian A, Shannon KM, Shaikh M, Bakay RA,
Kordower JH (2014) Progression of intestinal permeability changes and
alpha-synuclein expression in a mouse model of Parkinson’s disease. Mov
Disord 29: 999 – 1009
Kivipelto M, Solomon A, Ahtiluoto S, Ngandu T, Lehtisalo J, Antikainen R,
Bäckman L, Hänninen T, Jula A, Laatikainen T et al (2013) The Finnish
geriatric intervention study to prevent cognitive impairment and
disability (FINGER): study design and progress. Alzheimers Dement 9:
657 – 665
Kleino A, Silverman N (2019) Regulation of the Drosophila Imd pathway by
signaling amyloids. Insect Biochem Mol Biol 108: 16 – 23
Kundu P, Blacher E, Elinav E, Pettersson S (2017) Our gut microbiome: the
evolving inner self. Cell 171: 1481 – 1493
Lai CD, Xie M (2006) Stochastic ageing and dependence for reliability. New
York, NY: Springer Science & Business Media
Laparra JM, Sanz Y (2010) Interactions of gut microbiota with functional food
components and nutraceuticals. Pharmacol Res 61: 219 – 225
LeBlanc JG, Laiño JE, del Valle MJ, Vannini VV, van Sinderen D, Taranto MP, de
Valdez GF, de Giori GS, Sesma F (2011) B-Group vitamin production by
lactic acid bacteria–current knowledge and potential applications. J Appl
Microbiol 111: 1297 – 1309
LeBlanc JG, Milani C, de Giori GS, Sesma F, van Sinderen D, Ventura M (2013)
Bacteria as vitamin suppliers to their host: a gut microbiota perspective.
Curr Opin Biotechnol 24: 160 – 168
LeBlanc JG, Chain F, Martín R, Bermúdez-Humarán LG, Courau S, Langella P
(2017) Beneficial effects on host energy metabolism of short-chain fatty
acids and vitamins produced by commensal and probiotic bacteria. Microb
Cell Fact 16: 79
Lee RD (2007) Demographic change, welfare, and intergenerational transfers:
a global overview. In Ages, generations and the social contract, pp 17 – 43.
Dordrecht: Springer
Leser TD, Mølbak L (2009) Better living through microbial action: the benefits
of the mammalian gastrointestinal microbiota on the host. Environ
Microbiol 11: 2194 – 2206
Ley RE, Bäckhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI (2005)
Obesity alters gut microbial ecology. Proc Natl Acad Sci USA 102:
11070 – 11075
López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G (2013) The
hallmarks of aging. Cell 153: 1194 – 1217
Lunenfeld B, Stratton P (2013) The clinical consequences of an ageing
world and preventive strategies. Best Pract Res Clin Obstet Gynaecol 27:
643 – 659
Mändar R, Punab M, Borovkova N, Lapp E, Kiiker R, Korrovits P, Metspalu A,
Krjutskov K, Nolvak H, Preem JK et al (2015) Complementary
seminovaginal microbiome in couples. Res Microbiol 166: 440 – 447
Markenson GR, Adams LA, Hoffman DE, Reece MT (2003) Prevalence of
Mycoplasma bacteria in amniotic fluid at the time of genetic
amniocentesis using the polymerase chain reaction. J Reprod Med 48:
775 – 779
Martín R, Langa S, Reviriego C, Jimínez E, Marín ML, Xaus J, Rodríguez JM
(2003) Human milk is a source of lactic acid bacteria for the infant gut. J
Pediatr 143: 754 – 758
Martin-Ruiz C, Jagger C, Kingston A, Collerton J, Catt M, Davies K, Dunn M,
Hilkens C, Keavney B, Pearce SH et al (2011) Assessment of a large panel
of candidate biomarkers of ageing in the Newcastle 85 + study. Mech
Ageing Dev 132: 496 – 502
Miller ER, Erlinger TP, Appel LJ (2006) The effects of macronutrients on blood
pressure and lipids: an overview of the DASH and OmniHeart trials. Curr
Atheroscler Rep 8: 460 – 465
Montagu JD (1994) Length of life in the ancient world: a controlled study. J R
Soc Med 87: 25
Morris MC, Tangney CC, Wang Y, Sacks FM, Barnes LL, Bennett DA, Aggarwal
NT (2015b) MIND diet slows cognitive decline with aging. Alzheimers
Dement 11: 1015 – 1022
Morris MC, Tangney CC, Wang Y, Sacks FM, Bennett DA, Aggarwal NT (2015a)
MIND diet associated with reduced incidence of Alzheimer’s disease.
Alzheimers Dement 11: 1007 – 1014
Moschen AR, Wieser V, Tilg H (2012) Dietary factors: major regulators of the
gut’s microbiota. Gut Liv 6: 411
Natarajan N, Pluznick JL (2014) From microbe to man: the role of microbial
short chain fatty acid metabolites in host cell biology. Am J Physiol Cell
Physiol 307: C979 –C985
Nicholson JK, Holmes E, Kinross J, Burcelin R, Gibson G, Jia W, Pettersson S
(2012) Host-gut microbiota metabolic interactions. Science 336:
1262 – 1267
Olshansky SJ, Hayflick L, Carnes BA (2002) No truth to the fountain of youth.
Sci Am 286: 92 – 95
O’Toole PW, Claesson MJ (2010) Gut microbiota: changes throughout the
lifespan from infancy to elderly. Int Dairy J 20: 281 – 291
Park J, Kim M, Kang SG, Jannasch AH, Cooper B, Patterson J, Kim CH (2015)
Short-chain fatty acids induce both effector and regulatory T cells by
suppression of histone deacetylases and regulation of the mTOR–S6K
pathway. Mucosal Immunol 8: 80
Parkinson’s, UK (2018) The incidence and prevalence of Parkinson’s in the UK.
London, UK: Parkinson’s, UK
Passtoors WM, Beekman M, Deelen J, van der Breggen R, Maier AB, Guigas B,
Derhovanessian E, van Heemst D, de Craen AJ, Gunn DA et al (2013) Gene
expression analysis of mTOR pathway: association with human longevity.
Aging Cell 12: 24 – 31
ª 2019 The Authors EMBO Molecular Medicine 11: e9872 | 2019 11 of 12
Musarrat Maisha Reza et al EMBO Molecular Medicine
Pathak P, Xie C, Nichols RG, Ferrell JM, Boehme S, Krausz KW, Patterson AD,
Gonzalez FJ, Chiang JY (2018) Intestine farnesoid X receptor agonist and
the gut microbiota activate G-protein bile acid receptor-1 signaling to
improve metabolism. Hepatology 68: 1574 – 1588
Pfeiffer RF, Quigley EM (1999) Gastrointestinal motility problems in patients
with Parkinson’s disease. CNS Drugs 11: 435 – 448
Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, Nielsen T,
Pons N, Levenez F, Yamada T et al (2010) A human gut microbial
gene catalogue established by metagenomic sequencing. Nature
464: 59
Rattan SI (2005) Anti-ageing strategies: prevention or therapy?: Slowing
ageing from within. EMBO Rep 6(Suppl 1): S25 – S29
Rautava S, Collado MC, Salminen S, Isolauri E (2012) Probiotics modulate
host-microbe interaction in the placenta and fetal gut: a
randomized, double-blind, placebo-controlled trial. Neonatology 102:
178 – 184
Rivera JA, Barquera S, Campirano F, Campos I, Safdie M, Tovar V (2002)
Epidemiological and nutritional transition in Mexico: rapid increase of
non-communicable chronic diseases and obesity. Public Health Nutr 5:
113 – 122
Rosenberg A, Ngandu T, Rusanen M, Antikainen R, Bäckman L, Havulinna S,
Hänninen T, Laatikainen T, Lehtisalo J, Levälahti E et al (2018)
Multidomain lifestyle intervention benefits a large elderly population at
risk for cognitive decline and dementia regardless of baseline
characteristics: The FINGER trial. Alzheimers Dement 14: 263 – 270
Rossi M, Amaretti A, Raimondi S (2011) Folate production by probiotic
bacteria. Nutrients 3: 118 – 134
Schaible R, Ringelhan F, Kramer BH, Miethe T (2011) Environmental
challenges improve resource utilization for asexual reproduction and
maintenance in hydra. Exp Gerontol 46: 794 – 802
Schaible R, Sussman M (2013) FOXO in aging: did evolutionary diversification
of FOXO function distract it from prolonging life? BioEssays 35:
1101 – 1110
Semova I, Carten JD, Stombaugh J, Mackey LC, Knight R, Farber SA, Rawls JF
(2012) Microbiota regulate intestinal absorption and metabolism of fatty
acids in the zebrafish. Cell Host Microbe 12: 277 – 288
Siau ME (2017) Elderly to make up almost half of S’pore population by 2050:
United Nations. Retrieved from https://www.todayonline.com/singapore/
elderly-make-almost-half-spore-population-2050-united-nations
Simm A, Nass N, Bartling B, Hofmann B, Silber RE, Santos AN (2008) Potential
biomarkers of ageing. Biol Chem 389: 257 – 265
Sonowal R, Swimm A, Sahoo A, Luo L, Matsunaga Y, Wu Z, Bhingarde JA,
Ejzak EA, Ranawade A, Qadota H et al (2017) Indoles from
commensal bacteria extend healthspan. Proc Natl Acad Sci USA 114:
E7506 – E7515
Sorkin D, Rook KS, Lu JL (2002) Loneliness, lack of emotional support, lack of
companionship, and the likelihood of having a heart condition in an
elderly sample. Ann Behav Med 24: 290 – 298
Spor A, Koren O, Ley R (2011) Unravelling the effects of the environment and
host genotype on the gut microbiome. Nat Rev Microbiol 9: 279
Stewart CJ, Ajami NJ, O’Brien JL, Hutchinson DS, Smith DP, Wong MC, Ross
MC, Lloyd RE, Doddapaneni H, Metcalf GA et al (2018) Temporal
development of the gut microbiome in early childhood from the TEDDY
study. Nature 562: 583
Stout MJ, Conlon B, Landeau M, Lee I, Bower C, Zhao Q, Roehl KA, Nelson
DM, Macones GA, Mysorekar IU (2013) Identification of intracellular
bacteria in the basal plate of the human placenta in term and preterm
gestations. Am J Obstet Gynecol 208: 226.e1 – 226.e7
Sudo N, Chida Y, Aiba Y, Sonoda J, Oyama N, Yu XN, Kubo C, Koga Y (2004)
Postnatal microbial colonization programs the hypothalamic–pituitary–
adrenal system for stress response in mice. J Physiol 558: 263 – 275
Tangney CC (2014) DASH and Mediterranean-type dietary patterns to
maintain cognitive health. Curr Nutr Rep 3: 51 – 61
Tilg H, Kaser A (2011) Gut microbiome, obesity, and metabolic dysfunction.
J Clin Invest 121: 2126 – 2132
Trench RC (1874) Plutarch, his life, his parallel lives, and his morals. New York,
NY: Macmillan and Company
Verstraelen H, Vilchez-Vargas R, Desimpel F, Jauregui R, Vankeirsbilck N,
Weyers S, Verhelst R, De Sutter P, Pieper DH, Van De Wiele T (2016)
Characterisation of the human uterine microbiome in non-pregnant
women through deep sequencing of the V1-2 region of the 16S rRNA
gene. PeerJ 4: e1602
Walker ELAINE, Davis DANA, Baum K (1993) Social withdrawal. Symptoms of
Schizophrenia, pp 227 – 260. Toronto, ON: John Wiley & Sons Inc
Who J & Consultation F. E. (2003) Diet, nutrition and the prevention of
chronic diseases. World Health Organ Tech Rep Ser, 916(i-viii).
World Health Organization (2017a). Obesity and overweight. Retrieved from
http://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
World Health Organization (2017b). Diabetes. Retrieved from http://www.
who.int/news-room/fact-sheets/detail/diabetes
Zeevi D, Korem T, Zmora N, Israeli D, Rothschild D, Weinberger A, Ben-Yacov
O, Lador D, Avnit-Sagi T, Lotan-Pompan M et al (2015) Personalized
nutrition by prediction of glycemic responses. Cell 163: 1079 – 1094
Zglinicki TV, Martin-Ruiz CM (2005) Telomeres as biomarkers for ageing and
age-related diseases. Curr Mol Med 5: 197 – 203
Zhang C, Li S, Yang L, Huang P, Li W, Wang S, Zhao G, Zhang M, Pang X, Yan
Z et al (2013) Structural modulation of gut microbiota in life-long calorie-
restricted mice. Nat Commun 4: 2163
Zhao L, Shen J (2010) Whole-body systems approaches for gut microbiota-
targeted, preventive healthcare. J Biotechnol 149: 183 – 190
Zheng J, Xiao X, Zhang Q, Mao L, Yu M, Xu J (2015) The placental microbiome
varies in association with low birth weight in full-term neonates.
Nutrients 7: 6924 – 6937
Ziemer CJ, Gibson GR (1998) An overview of probiotics, prebiotics and
synbiotics in the functional food concept: perspectives and future
strategies. Int Dairy J 8: 473 – 479
Zmora N, Suez J, Elinav E (2018) You are what you eat: diet, health and the
gut microbiota. Nat Rev Gastroenterol Hepatol 16: 35 – 56
License: This is an open access article under the
terms of the Creative Commons Attribution 4.0
License, which permits use, distribution and reproduc-
tion in any medium, provided the original work is
properly cited.
12 of 12 EMBO Molecular Medicine 11: e9872 | 2019 ª 2019 The Authors
EMBO Molecular Medicine Musarrat Maisha Reza et al
